| CHCHD6 Protein | |
|---|---|
| Protein Name | Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 6 |
| Gene | [CHCHD6](/genes/chchd6) |
| UniProt ID | [Q9BYX7](https://www.uniprot.org/uniprot/Q9BYX7) |
| Molecular Weight | ~29 kDa |
| Subcellular Localization | Mitochondria (inner membrane) |
| Protein Family | CHCH domain family |
CHCHD6 (Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 6) is a mitochondrial protein encoded by the CHCHD6 gene located on chromosome 3p24.3. The protein contains characteristic twin CX9C motifs within its CHCH (coiled-coil-helix-coiled-coil-helix) domains, which are conserved across eukaryotic organisms and mediate protein-protein interactions in mitochondrial intermembrane space [1]. CHCHD6 plays essential roles in mitochondrial function, cellular respiration, and iron-sulfur cluster biogenesis. Recent research has implicated CHCHD6 in the pathogenesis of neurodegenerative diseases, particularly Parkinson's disease, where mitochondrial dysfunction is a central pathological feature [2].
The CHCHD6 protein possesses a distinctive structural architecture characterized by:
The CX9C motif is evolutionarily conserved and shared with several other mitochondrial proteins involved in oxidative phosphorylation, including CHCHD2, CHCHD3, CHCHD10, and COX19 [3].
CHCHD6 is a critical component of the mitochondrial respiratory chain. It associates with complex I (NADH:ubiquinone oxidoreductase) and complex IV (cytochrome c oxidase) of the electron transport chain [1]. The protein participates in:
CHCHD6 participates in the mitochondrial iron-sulfur cluster (Fe-S) assembly pathway, which is essential for the function of Fe-S proteins in the respiratory chain [4]. Fe-S clusters serve as:
The protein contributes to mitochondrial morphology and dynamics by interacting with the mitochondrial inner membrane fusion machinery [5]. It helps maintain:
CHCHD6 has emerged as a significant player in Parkinson's disease pathogenesis. Multiple lines of evidence support its involvement:
Genetic Associations: While direct CHCHD6 mutations have not been definitively linked to familial PD, the protein's function is disrupted in PD brain tissue [2]. Studies have shown:
Mitochondrial Dysfunction: The hallmark pathological feature of PD—loss of dopaminergic neurons in the substantia nigra—is closely tied to mitochondrial impairment [6]. CHCHD6 contributes to:
Therapeutic Implications: CHCHD6 and related mitochondrial proteins represent potential therapeutic targets for PD [7]. Strategies under investigation include:
Emerging evidence suggests CHCHD6 may play a role in ALS pathogenesis. The protein shares structural and functional similarities with CHCHD10, which has been directly linked to ALS [8]. Both proteins:
CHCHD6 expression is altered in several cancers, where it influences cellular metabolism [9]. The protein's role in oxidative phosphorylation affects:
CHCHD6 interacts with several proteins involved in mitochondrial function:
| Protein | Interaction Type | Functional Significance |
|---|---|---|
| CHCHD2 | Heterodimer | Mitochondrial respiration, PD pathogenesis |
| CHCHD3 | Heterodimer | Mitochondrial inner membrane organization |
| CHCHD10 | Heterodimer | Respiratory chain assembly, ALS link |
| Complex I subunits | Structural | Electron transport chain function |
| Complex IV subunits | Structural | Cytochrome c oxidase assembly |
CHCHD6 represents a potential therapeutic target for neurodegenerative diseases:
CHCHD6 levels may serve as biomarkers for mitochondrial dysfunction in neurodegenerative diseases: